Expansion Sees Q Chip Move to new Facility
News Oct 15, 2008
Q Chip Ltd, a developer of microencapsulation solutions, has officially opened its new corporate headquarters and R&D facility in Cardiff. The expansion into new headquarters marks a significant step in the steady expansion Q Chip has experienced since its foundation.
In summer 2007 Q Chip successfully completed a funding round which saw it raise in excess of £2 million from existing and new shareholders. This investment is being used to expand the product range of ReaX™ encapsulated PCR reagents, Biologix™ microspheres for peptide delivery and cell encapsulation, as well as Q Chip’s proprietary MicroPlant™ microfluidic device.
The MicroPlant produces microspheres of extreme uniformity that encapsulate all the reagents needed to perform a PCR. This means that ReaX assays require minimal user input, time and skill level giving reproducible results.
The MicroPlant production technology also offers significant benefits compared to conventional microencapsulation processes, such as ultra-low wastage, uniform dosing and morphology, and low process costs.
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018